ArticleTranslational pediatrics2024

Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trial.

Li-Ting Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.